Deals

BioNTech
Favicon Fierce Biotech

BioNTech buys German mRNA vaccine peer CureVac in $1.2B deal

BioNTech is buying fellow German mRNA vaccine developer CureVac in an all-stock transaction that values the acquired biotech at $1.25 billion.
James Waldron Jun 12, 2025 8:17am
photo of a pair of binoculars perched on a rock aimed at the rising sun
Favicon Fierce Biotech

Are Lilly, Novartis eyeing the PD-1xVEGF field? Execs weigh in

Jun 4, 2025 1:00pm
two jiggsaw puzzles connected with drawn hands shaking on the two puzzles

Agenus transfers pair of CA plants to Zydus as part of $141M pact

Jun 3, 2025 9:32am
Deal terminate tear up end deal scrap
Favicon Fierce Biotech

HHS axes Moderna's $590M pandemic bird flu vaccine contract

May 29, 2025 4:30am
Novartis

Novartis expands collaboration with Shanghai Pharma in China

May 27, 2025 10:08am
european euros

Zentiva inks €220M deal for former AstraZeneca GI drug in Europe

May 22, 2025 1:30am